BIOMAT Database Logo BIOMAT Database Logo

Treatment of Gram negative meningitis with cefotaxime. 1983

M P Glauser, and R O Mirimanoff, and N de Tribolet

The authors report on the successful cefotaxime treatment (one of the newer cephalosporins) of K. pneumoniae meningitis which developed while the patient was under treatment with an older cefalosporin, cephalothin.

UI MeSH Term Description Entries
D007710 Klebsiella Infections Infections with bacteria of the genus KLEBSIELLA. Infections, Klebsiella,Infection, Klebsiella,Klebsiella Infection
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D008297 Male Males
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

M P Glauser, and R O Mirimanoff, and N de Tribolet
Effectiveness of cefotaxime in gram-negative meningitis.
November 1984, Neurosurgery,
M P Glauser, and R O Mirimanoff, and N de Tribolet
Cefotaxime therapy of neonatal gram-negative bacillary meningitis.
January 1985, Pediatric infectious disease,
M P Glauser, and R O Mirimanoff, and N de Tribolet
Cefotaxime treatment of gram-negative enteric meningitis in infants and children.
January 1988, Drugs,
M P Glauser, and R O Mirimanoff, and N de Tribolet
Relapse of gram-negative bacillary meningitis after cefotaxime therapy.
September 1982, JAMA,
M P Glauser, and R O Mirimanoff, and N de Tribolet
Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms.
November 1990, The Pediatric infectious disease journal,
M P Glauser, and R O Mirimanoff, and N de Tribolet
Cefotaxime for treatment of gram-negative bacterial meningitis in infants and children.
May 1987, The Pediatric infectious disease journal,
M P Glauser, and R O Mirimanoff, and N de Tribolet
Treatment of gram-negative bacterial meningitis.
September 1987, The Western journal of medicine,
M P Glauser, and R O Mirimanoff, and N de Tribolet
[The treatment of gram-negative meningitis].
October 1983, Harefuah,
M P Glauser, and R O Mirimanoff, and N de Tribolet
[Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)].
February 1981, La Nouvelle presse medicale,
M P Glauser, and R O Mirimanoff, and N de Tribolet
Successful treatment of gram-negative bacillary meningitis with moxalactam.
June 1982, Neurosurgery,
Copied contents to your clipboard!